Management Guidelines

NICE Guidance

The National Institute for Health and Clinical Excellence (NICE) is an independent organisation which is responsible for giving national guidance in the UK on the promotion of good health and the prevention and treatment of ill-health.

NICE guidance is developed using the expertise of the NHS and the wider healthcare community including healthcare professionals, patients and carers, industry and the academic world.

The guidance covers three areas of health:

1. Clinical practice - guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS;
2. Health technologies - guidance on the use of new and existing medicines, treatments and procedures within the NHS;
3. Public health - guidance on the promotion of good health and the prevention of ill health for people working in the NHS, local authorities and the wider public and voluntary sectors.
   

The NICE website - which contains all the guidance - can be found at www.nice.org.uk
Once on the home page a search facility will allow you to access NICE guidance on any health topic. For example, if you type in ‘liver’ you will be able to access the 30 current guidelines relating to the treatment of liver conditions.

An advanced search button can also be used which allows you to tailor a search more closely.

 

The Scottish Intercollegiate Guidelines Network (SIGN)

The Scottish Intercollegiate Guidelines Network (SIGN) develops evidence-based clinical practice guidelines for the National Health Service (NHS) in Scotland. SIGN guidelines are derived from a systematic review of the scientific literature and are designed as a vehicle for accelerating the translation of new knowledge into action to meet its aim of reducing variations in practice, and improving patient-important outcomes.

Relevant guidelines for AUGIS members include:

106 Control of pain in adults with cancer:
http://www.sign.ac.uk/guidelines/fulltext/106/index.html

105 Management of acute upper and lower gastrointestinal bleeding:
http://www.sign.ac.uk/guidelines/fulltext/105/index.html

104 antibiotic prophylaxis in surgery:
http://www.sign.ac.uk/guidelines/fulltext/104/index.html

 

Guidelines for the management of gastrointestinal stromal tumours (GISTS)

Click here to read the Management Guidelines document

Authors

Robin Reid, Consultant Pathologist, Western Infirmary, Glasgow (chair)
Ramesh Bulusu, Consultant Oncologist, Addenbrooke’s Hospital, Cambridge
John Buckels, Consultant Surgeon, Queen Elizabeth Medical Centre, Birmingham
Nicholas Carroll, Consultant Radiologist, Addenbrooke’s Hospital, Cambridge
Martin Eatock, Consultant Oncologist, Belfast City Hospital, Belfast
Ian Geh, Consultant Oncologist, Birmingham Heartlands Hospital, Birmingham
Richard Hardwick, Consultant Surgeon, Addenbrooke’s Hospital, Cambridge
Ian Judson, Consultant Oncologist, Royal Marsden Hospital, London
Paddy O’Dwyer, Consultant Surgeon, Western Infirmary, Glasgow
Sarah O’Dwyer, Consultant Surgeon, Christie Hospital, Manchester
Ashley Roberts, Consultant Radiologist, University Hospital of Wales, Cardiff
Martin Robinson, Consultant Oncologist, Western Park Hospital, Sheffield
Simon Toh, Consultant Surgeon, Queen Alexandra Hospital, Portsmouth
Bryan Warren, Consultant Pathologist, John Radcliffe Hospital, Oxford

Contributors

Michael Leahy, Consultant Oncologist, St James’ Hospital, Leeds
Supported by an educational grant from Novartis Oncology.